{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:48:39Z","timestamp":1790772519707,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.tips.2003.11.003","type":"journal-article","created":{"date-parts":[[2003,12,12]],"date-time":"2003-12-12T16:09:13Z","timestamp":1071245353000},"page":"42-48","source":"Crossref","is-referenced-by-count":125,"title":["Current pharmacological treatments for nicotine dependence"],"prefix":"10.1016","volume":"25","author":[{"given":"Tony P","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2003.11.003_BIB1","first-page":"300","article-title":"Cigarette smoking among adults in the United States, 2002","volume":"51","year":"2002","journal-title":"Morbidity and Mortality World Report"},{"key":"10.1016\/j.tips.2003.11.003_BIB2","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1038\/sj.onc.1205808","article-title":"Epidemiology of tobacco use in the United States","volume":"21","author":"Giovino","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2003.11.003_BIB3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/1462220031000070534","article-title":"The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials","volume":"5","author":"Irvin","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1360-0443.1996.tb03802.x","article-title":"The future of smoking cessation therapy in the United States","volume":"91","author":"Hughes","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.tips.2003.11.003_BIB5","first-page":"35","article-title":"Smoking cessation and gender: the influence of physiological, psychological and behavioral factors","volume":"51","author":"Gritz","year":"1996","journal-title":"J. Am. Med. Womens Assoc."},{"key":"10.1016\/j.tips.2003.11.003_BIB6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14622299050011431","article-title":"Sex-differences in nicotine effects and self-administration: review of human and animal evidence","volume":"1","author":"Perkins","year":"1999","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0091-3057(01)00652-9","article-title":"Cellular mechanisms of nicotine addiction","volume":"70","author":"Dani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tips.2003.11.003_BIB8","first-page":"494","article-title":"Nicotine as a modulator of behavior: beyond the inverted U","volume":"23","author":"Picciotto","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2003.11.003_BIB9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain: Links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2003.11.003_BIB10","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1523\/JNEUROSCI.23-08-03176.2003","article-title":"Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas","volume":"23","author":"Wooltorton","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2003.11.003_BIB11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14622200110050213","article-title":"Neuronal nicotinic receptors: from structure to function","volume":"3","author":"Leonard","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB12","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2003.11.003_BIB13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.10148","article-title":"Cellular and synaptic mechanisms of nicotine addiction","volume":"53","author":"Mansvelder","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.tips.2003.11.003_BIB14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","article-title":"Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated animals","volume":"68","author":"Marshall","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2003.11.003_BIB15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","article-title":"Inhibition of monoamine oxidase B in the brains of smokers","volume":"379","author":"Fowler","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.tips.2003.11.003_BIB16","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1073\/pnas.93.24.14065","article-title":"Brain monoamine oxidase A: inhibition by cigarette smoke","volume":"93","author":"Fowler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2003.11.003_BIB17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJMcp012279","article-title":"Treatment of tobacco use and dependence","volume":"346","author":"Rigotti","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB18","unstructured":"First, M.B. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn, American Psychiatric Association, Washington."},{"key":"10.1016\/j.tips.2003.11.003_BIB19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.tips.2003.11.003_BIB20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ntr\/5.1.13","article-title":"Measurement of abstinence in clinical trials: issues and recommendations","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00213-002-1338-1","article-title":"Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving","volume":"166","author":"Shiffman","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2003.11.003_BIB22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14622200110042624","article-title":"Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking","volume":"3","author":"Cousins","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1378\/chest.121.3.932","article-title":"Treating tobacco use and dependence: An evidence-based clinical practice guideline for tobacco cessation","volume":"121","author":"Anderson","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.tips.2003.11.003_BIB24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jama.275.16.1270","article-title":"The agency for health care policy and research smoking cessation clinical practice guidelines","volume":"275","author":"Fiore","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2003.11.003_BIB25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.281.1.72","article-title":"Recent advances in the pharmacotherapy of smoking","volume":"281","author":"Hughes","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2003.11.003_BIB26","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1001\/jama.271.24.1940","article-title":"The effectiveness of the nicotine patch for smoking cessation: a meta-analysis","volume":"271","author":"Fiore","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2003.11.003_BIB27","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB28","first-page":"321","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologic relapse-prevention after smoking cessation: a randomized, controlled trial","volume":"135","author":"Hays","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/bmj.326.7396.952\/a","article-title":"GlaxoSmithKline takes legal action to block new controls on its smoking cessation drug","volume":"326","author":"Sweet","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.tips.2003.11.003_BIB32","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1001\/archinte.160.20.3128","article-title":"Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial","volume":"160","author":"Bohadana","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.1994.105","article-title":"Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone","volume":"56","author":"Rose","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1037\/1064-1297.6.3.331","article-title":"Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy","volume":"6","author":"Rose","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2003.11.003_BIB36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1360-0443.1999.948122713.x","article-title":"A randomized trial of naltrexone for smoking cessation","volume":"94","author":"Wong","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.tips.2003.11.003_BIB37","doi-asserted-by":"crossref","unstructured":"Krishnan-Sarin, S. et al. Nicotine patch and naltrexone for smoking cessation: a preliminary study. Nicotine Tob. Res. (in press).","DOI":"10.1080\/14622200310001614601"},{"key":"10.1016\/j.tips.2003.11.003_BIB38","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.158.18.2035","article-title":"A randomized trial of nortriptyline for smoking cessation","volume":"158","author":"Prochazka","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tips.2003.11.003_BIB39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.55.8.683","article-title":"Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking","volume":"55","author":"Hall","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archpsyc.59.10.930","article-title":"Psychological intervention and antidepressant treatment in smoking cessation","volume":"59","author":"Hall","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/ajp.146.3.373","article-title":"Doxepin as an adjunct to smoking cessation: a double-blind pilot study","volume":"146","author":"Edwards","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0009-9236(95)90058-6","article-title":"A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers","volume":"58","author":"Berlin","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01454-3","article-title":"A preliminary trial of selegiline hydrochloride versus placebo for smoking cessation","volume":"53","author":"George","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain: Links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2003.11.003_BIB45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1037\/0022-006X.70.4.887","article-title":"Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment","volume":"70","author":"Niaura","year":"2002","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.tips.2003.11.003_BIB46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1037\/0022-006X.68.5.883","article-title":"Nicotine patch and paroxetine for smoking cessation","volume":"68","author":"Killen","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.tips.2003.11.003_BIB47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1360-0443.1999.94710076.x","article-title":"The effects of fluoxetine combined with nicotine inhalers in smoking cessation","volume":"94","author":"Blondal","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.tips.2003.11.003_BIB48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1037\/0022-006X.67.4.547","article-title":"Antidepressant pharmacotherapy helps some cigarette smokers more than others","volume":"67","author":"Hitsman","year":"1999","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.tips.2003.11.003_BIB49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0009-9236(96)90153-8","article-title":"Efficacy of buspirone in smoking cessation: a placebo-controlled trial","volume":"60","author":"Schneider","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1360-0443.1991.tb01860.x","article-title":"A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation","volume":"86","author":"Covey","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.tips.2003.11.003_BIB51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003495-199550020-00001","article-title":"Is clonidine an effective smoking cessation therapy?","volume":"50","author":"Gourlay","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2003.11.003_BIB52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1037\/1064-1297.4.3.285","article-title":"Transdermal clonidine for smoking cessation: a double-blind randomized dose-response study","volume":"4","author":"Niaura","year":"1996","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2003.11.003_BIB53","first-page":"87","article-title":"Clonidine for smoking cessation","volume":"81","author":"Nana","year":"1998","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.tips.2003.11.003_BIB54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0306-4530(97)00074-7","article-title":"Endogenous opioids and smoking: A review of progress and problems","volume":"23","author":"Pomerleau","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tips.2003.11.003_BIB55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.56.7.663","article-title":"Naloxone challenge in smokers: Evidence for an opioid component in nicotine dependence","volume":"56","author":"Krishnan-Sarin","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02245813","article-title":"Naltrexone, smoking behavior and cigarette withdrawal","volume":"120","author":"Sutherland","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2003.11.003_BIB57","first-page":"88","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.1991.tb01797.x","article-title":"Nicotinic receptor blockade therapy and smoking cessation","volume":"86","author":"Clarke","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.tips.2003.11.003_BIB59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00429305","article-title":"Influencing cigarette smoking with nicotinic antagonists","volume":"28","author":"Stolerman","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.tips.2003.11.003_BIB60","first-page":"125","article-title":"Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion","volume":"271","author":"Collins","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB61","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","article-title":"Nicotinic enhancment of fast excitatory synaptic transmission in CNS by presynaptic receptors","volume":"269","author":"McGehee","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.tips.2003.11.003_BIB62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14622200110042624","article-title":"Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking","volume":"3","author":"Cousins","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB63","first-page":"65","article-title":"Rimonabant SR 141716, SR 141716a","volume":"3","year":"2002","journal-title":"Drugs R D."},{"key":"10.1016\/j.tips.2003.11.003_BIB64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","article-title":"The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice","volume":"167","author":"Paterson","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2003.11.003_BIB65","first-page":"688","article-title":"The novel 5-hydroxytryptamine 1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine","volume":"294","author":"Rasmussen","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2003.11.003_BIB66","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.npp.1300183","article-title":"Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior","volume":"28","author":"Andreoli","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2003.11.003_BIB67","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1517\/13543784.10.10.1819","article-title":"The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control (review)","volume":"10","author":"Decker","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tips.2003.11.003_BIB68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/alcalc\/37.5.495","article-title":"Baclofen antagonizes intravenous self-administration of nicotine in mice and rats","volume":"37","author":"Fattore","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.tips.2003.11.003_BIB69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0091-3057(00)00436-6","article-title":"Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome","volume":"68","author":"Malin","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tips.2003.11.003_BIB70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1993.01820130038007","article-title":"Smoking and major depression: a causal analysis","volume":"50","author":"Kendler","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.55.8.683","article-title":"Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking","volume":"55","author":"Hall","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB72","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2003.11.003_BIB73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/1462220031000073298","article-title":"Naltrexone treatment for alcoholics: Effects on cigarette smoking rates","volume":"5","author":"Rosenhow","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.tips.2003.11.003_BIB74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00008571-200211000-00007","article-title":"Pharmacogenetic investigation of smoking cessation treatment","volume":"12","author":"Lerman","year":"2002","journal-title":"Pharmacogenetics"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561470300350X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561470300350X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T01:59:41Z","timestamp":1585360781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561470300350X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S016561470300350X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2003.11.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}